Tonya Politano
Medical · Saint Cloud, FLNPI 1013018571
Payments from drug & device makers
Across 151 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$402
- Boehringer Ingelheim$362
- AstraZeneca$273
- Bayer$265
- Novo Nordisk$259
- AbbVie$213
- plus $728 from 14 others
What the payments were for
- Food & beverage$2,48199%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 27 | $402 |
| Boehringer Ingelheim | 18 | $362 |
| AstraZeneca | 15 | $273 |
| Bayer | 11 | $265 |
| Novo Nordisk | 14 | $259 |
| AbbVie | 16 | $213 |
| Pfizer | 9 | $178 |
| Lilly USA, LLC | 13 | $144 |
| GSK | 7 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $92 |
| Merck | 3 | $45 |
| Agile Therapeutics, Inc. | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| Abbott | 1 | $21 |
| Phadia US Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
| Genentech USA, Inc. | 1 | $5 |
How this compares
$2,501 in reported general payments places this provider in the 75th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,599 |
| Levothyroxine Sodium | 43 | $574 |
| Omeprazole | 30 | $521 |
| Losartan Potassium | 44 | $393 |
| Famotidine | 15 | $347 |
| Pravastatin Sodium | 26 | $324 |
| Atorvastatin Calcium | 19 | $278 |
| Montelukast Sodium | 23 | $276 |
| Rosuvastatin Calcium | 25 | $248 |
| Amlodipine Besylate | 34 | $183 |
| Lisinopril | 18 | $123 |
| Simvastatin | 12 | $71 |
| Alprazolam | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaSymbicort | $273 | $2,59911 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $11 | $57443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,031 medical providers in Florida.
Other medical in Saint Cloud
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.